Pentacam AXL Wave REF 70020. Used to image the anterior segment of the eye.

FDA Device Recall #Z-1672-2022 — Class II — July 8, 2022

Recall Summary

Recall Number Z-1672-2022
Classification Class II — Moderate risk
Date Initiated July 8, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Oculus Optikgeraete GMBH
Location Wetzlar
Product Type Devices
Quantity 21 systems with affected software

Product Description

Pentacam AXL Wave REF 70020. Used to image the anterior segment of the eye.

Reason for Recall

Due to a software issue, IOL calculator printout often does not accurately reflect the alignment axis and incision position when planning toric IOLs

Distribution Pattern

U.S.: AL, AR, AZ, CAQ, CO, CT, FL, GA, HI, IA, ID, IL, KS, KY, MD, ME, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NY, OH, PA, Puerto Rico, SC, SD, TN, TX, UT, VA, WA, WI, and WY O.U.S.: N/A

Lot / Code Information

Software version: 1.26r26 and 1.26r27 Model Number: 70020 UDI-DI Code: 04049584025357 Serial Numbers: 70020 0111 0201 70020 0211 0201 70020 0311 0211 70020 0711 1230 70020 1211 0201 70020 1321 1211 70020 2411 0211 70020 2911 1250 70020 3511 0211 70020 3801 0230 70020 4701 0210 70020 4811 1250 70020 5411 0211 70020 5701 0210 70020 6611 1230 70020 6621 1211 70020 7011 0201 70020 7511 1230 70020 8021 1290 70020 8701 0210 70020 9011 0201

Other Recalls from Oculus Optikgeraete GMBH

Recall # Classification Product Date
Z-2483-2023 Class II Oculus Pentacam AXL , Ref 70100, CE 0123 Aug 8, 2023
Z-2484-2023 Class II Oculus Myopia Master , Ref 68100, CE 0123 Aug 8, 2023
Z-2482-2023 Class II Oculus Pentacam AXL Wave, Ref 70020, CE 0123 Aug 8, 2023
Z-1673-2022 Class II Pentacam AXL REF 70100, Pentacam HR REF 7090... Jul 8, 2022
Z-1674-2022 Class II Pentacam HR REF 70900. Used to image the anter... Jul 8, 2022

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.